• ADAMTS2 Gene Mutation Analysis
  • 5-Fluorouracil (5-FU) Toxicity and Chemotherapeutic Response, 5 Mutations
  • Nocardia Culture and Gram Stain
  • Allergen Specific IgE, Respiratory (Environmental Inhalant) Profile
  • Glycyphagus domesticus, IgE
  • Cocaine Metabolites, Urine
  • UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue
  • 17-Hydroxyprogesterone, Amniotic fluid
  • 14-3-3 Protein Tau/Theta, Spinal Fluid
  • Ecstasy, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
Medical Test

Turnaround Time
Access to Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism is restricted.
Loading...